Format

Send to

Choose Destination
BMJ Case Rep. 2019 Sep 8;12(9). pii: e231097. doi: 10.1136/bcr-2019-231097.

Intravitreal bevacizumab in treatment of iris metastasis from primary lung carcinoma.

Author information

1
Vitreoretina, LVPEI, Vijayawada, Andra Pradesh, India.
2
LV Prasad Eye Institute, Visakhapatnam, Andhra Pradesh, India.
3
Ophthalmic Pathology, LV Prasad Eye Institute, Bhubaneswar, Odisha, India.
4
LV Prasad Eye Institute, Hyderabad, Telangana, India.

Abstract

Iris metastases secondary to primary malignancy are rare and usually have poor overall survival. We report a case of a man aged 60 years who presented with chief complaints of progressive pain and redness of right eye of 5 days duration. Slit-lamp examination revealed a greyish white irregular nodular mass, arising from anterior iris surface reaching up to mid-periphery. With a clinical suspicion of iris metastasis, systemic investigations were requested. CT scan of chest reported a well-defined lobulated lesion in the lower lobe of lung with presence of multiple satellite nodules in both lungs suggestive of primary malignant neoplasm of lung. Tissue diagnosis was obtained through an iris lesion biopsy, which was opted for relative ease of approach. Histopathology and immunohistochemistry confirmed the diagnosis of iris metastasis secondary to non-keratinising squamous cell carcinoma of lung. Local intravitreal injection of antivascular endothelial growth factor was administered for tumour regression along with systemic chemotherapy.

KEYWORDS:

Eye; Iris; Lung Cancer (oncology); Pathology

PMID:
31501176
DOI:
10.1136/bcr-2019-231097

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center